Table 4.

Percentages of women receiving AOM by diagnosis (osteoporosis, osteopenia, or neither) and fracture risk factors.

	n	Low risk			High risk
		Osteopenia (n=745)	Osteoporosis (n=252)	Neither (n=2016)	Osteopenia (n=839)	Osteoporosis (n=1321)	Neither (n=1539)
Total	6538	28.7	62.4	1.6	39.5	65.4	7.6
Education
High school or less	1751	28.9	51.0	2.4	35.4	60.5	8.5
More than high school	4711	28.7	65.3	1.4	40.7	68.3	6.9
Race
White	5920	28.5	62.7	1.3	39.8	66.4	7.4
Non-white	566	34.0	62.5	3.3	30.3	49.4	10.0
Number of comorbidities
0	1410	30.7	68.7	2.5	46.2	76.1	10.6
≥1	4849	27.6	58.7	1.2	38.1	64.7	7.2
General health
Excellent/very good/good	5649	29.4	61.4	1.6	40.3	69.7	7.6
Fair/poor	843	13.8	70.0	1.4	37.0	50.5	8.3
Prescription drug coverage
No	423	3.4	20.0	0.8	31.3	54.4	9.3
Yes	6096	29.8	64.3	1.6	39.9	66.4	7.5
Concern about osteoporosis
Very/somewhat	5683	28.9	63.3	1.8	39.9	65.4	9.1
Not at all	836	21.7	20.0	0.5	30.8	69.8	2.8
Perceived fracture risk
Same/lower than others	4944	24.8	56.0	1.5	37.8	61.0	7.3
Higher than others	1510	42.3	70.4	4.1	43.7	69.6	9.3
Vitality score
≤median (62.5)	3578	23.3	54.5	1.1	36.0	61.3	6.2
>median (62.5)	2939	32.8	69.5	2.1	43.9	72.5	9.6
Physical function score
≤median (85)	3087	23.7	51.6	1.9	37.1	62.9	7.5
>median (85)	3433	30.0	66.1	1.5	42.7	70.5	7.8

Data are %.

AOM, anti-osteoporosis medication.